Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0A4Y stock hub

LON/0A4Y has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0A4Yis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0A4Y

In the news

Latest news · LON/0A4Y

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0A4Y market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

150

Groups with data

Currency

USD

Showing 150 of 150 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	21
Employees Change	-2%
Employees Change Percent	-8.7
Enterprise value	$3.4M
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	$2M
Price	$0.36
Price currency	USD
Rev Per Employee	3,269.2x
Sic	2836
Symbol	lon/0A4Y
Website	https://aimimmuno.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-513.29%
EV Earnings	-0.33x
EV/Sales	52.3x
P/B ratio	-0.28x
P/S ratio	30.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-45.45%
Gross Profit	$-29,720
Net Income	$-10.4M
Pretax Margin	-15,861.36%
Profit Per Employee	$-518,540
ROA	-101.3
Roa5y	-59.81
ROCE	2,638.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.81%
Cagr3y	-77.71%
Cagr5y	-69.59%
Revenue Growth	-48.24x
Revenue Growth Q	-53.33x
Revenue Growth3 Y	-14.54x
Revenue Growth5 Y	-11.6x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.01
Assets	$4.3M
Cash	$2.3M
Current Assets	$2.4M
Current Liabilities	$4.6M
Debt	$3.6M
Equity	$-7.3M
Interest Coverage	-14.36
Liabilities	$11.6M
Long Term Assets	$1.9M
Long Term Liabilities	$7M
Net Cash	$-1.4M
Net Cash By Market Cap	$-67.99
Tangible Book Value	$-8.5M
Tangible Book Value Per Share	$-2.77
WACC	12.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.53
Net Working Capital	$-1.6M
Quick ratio	0.49
Working Capital	$-2.2M
Working Capital Turnover	$-0.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-188.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.8%
200-day SMA	3.03
3Y total return	-98.89%
50-day SMA	0.65
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.74%
All Time High	303.7
All Time High Change	-99.82%
All Time High Date	2021-02-10
All Time Low	0.35
All Time Low Change	58.11%
All Time Low Date	2026-05-08
ATR	0.08
Beta	1.24
Ch YTD	-51.87
High	0.58
High52	34.14
High52 Date	2025-07-28
High52ch	-98.94%
Low	0.35
Low52	0.35
Low52 Date	2026-05-08
Low52ch	4.4%
Ma50ch	-15.65%
Price vs 200-day SMA	-81.98%
RSI	31.14
RSI Monthly	26.33
RSI Weekly	29.72
Sharpe ratio	-1.24x
Sortino ratio	-1.69
Total Return	-188.95%
Tr YTD	-51.86
Tr1m	-0.15%
Tr1w	7.02%
Tr3m	-50.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-8.7M
Operating margin	-13,254.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	7,988,773%
Net Borrowing	1,533,044.3
Shares Insiders	1.95%
Shares Institutions	1.71%
Shares Qo Q	37.65%
Shares Yo Y	188.95%
Short Ratio	0.07

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	10,624.35x
Bv Per Share	-2.37
Ch1m	-0.15
Ch1w	7.02
Ch1y	-94.8
Ch3m	-50.38
Ch3y	-98.89
Ch5y	-99.74
Ch6m	-65.41
Change	-33.97%
Change From Open	-37.69
Close	0.55
Days Gap	5.97
Depreciation Amortization	154,037.9
Dollar Volume	24,476.6
Earnings Date	2026-05-18
EBIT	$-8.7M
EBITDA	$-8.5M
EPS	$-6.41
F Score	3
Financing CF	7,718,284
Fiscal Year End	December
Founded	1,966
Investing CF	1,376,779
Is Primary Listing	0
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Last Split Date	2026-01-09
Last Split Type	Forward
Ma150	1.4
Ma150ch	-61.1%
Ma20	0.51
Ma20ch	6.23%
Net CF	954,012
Next Earnings Date	2026-05-18
Open	0.58
Position In Range	6.52
Ppne	329,347.8
Price Date	2026-05-08
Relative Volume	6.39x
Revenue	65,384x
SBC By Revenue	68.18x
Share Based Comp	44,580
Tr6m	-65.42%
Volume	67,915
Z Score	-113.7

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0A4Y pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0A4Y stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0A4Y?

Insider, institutional, and short-interest positioning.

Institutional ownership

+1.7%

Share of float held by funds and institutions

Insider ownership

+2.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0A4Y momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.1

Neutral momentum band

Price vs 200-day MA

-82.0%

50/200-day relationship not available

Beta (5Y)

1.24

More volatile than the market

Sharpe ratio

-1.24

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0A4Y

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0A4Y stock rating?

lon/0A4Y is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0A4Y analysis?

The full report lives at /stocks/lon/0A4Y/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0A4Y?

The latest report frames lon/0A4Y around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0A4Y page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.